Original Research
AB060. A predictive model for surgical resectability in thymic epithelial tumors using clinical data: a step towards integrating radiomics and histopathology
Mediastinum
2025;
9:
AB060
.
(30 September 2025)
Original Research
AB059. Enrollment in clinical trials among Italian patients with metastatic thymic epithelial tumors: a retrospective TYME network analysis
Mediastinum
2025;
9:
AB059
.
(30 September 2025)
Original Research
AB058. Surgical management of TNM stage IVA thymoma and thymic carcinoma: the network TYME experience (4TYMEs)
Mediastinum
2025;
9:
AB058
.
(30 September 2025)
Original Research
AB057. Two decades of robotic thymectomy: trends and insights from a retrospective study
Mediastinum
2025;
9:
AB057
.
(30 September 2025)
Original Research
AB056. Surgical outcomes and prognostic impact of complete resection in thymic epithelial tumors: a 15-year experience from the National Cancer Institute of Mexico
Mediastinum
2025;
9:
AB056
.
(30 September 2025)
Original Research
AB055. FGFR1 amplification in thymic epithelial tumors (TETs): a study from 48 cases
Mediastinum
2025;
9:
AB055
.
(30 September 2025)
Original Research
AB054. Survival outcomes in thymic carcinoma: a single-center experience
Mediastinum
2025;
9:
AB054
.
(30 September 2025)
Original Research
AB053. The role of local therapy in oligo-recurrent metastatic thymic epithelial tumors: a monocentric retrospective analysis
Mediastinum
2025;
9:
AB053
.
(30 September 2025)
Study Protocol
AB052. Indications for postoperative radiation therapy for thymic tumors based on the new ninth TNM stage classification: a protocol of a multicenter, retrospective study
Mediastinum
2025;
9:
AB052
.
(30 September 2025)
Original Research
AB051. Immunopathological profile of patients with thymic epithelial tumour and Good syndrome in advanced stage
Mediastinum
2025;
9:
AB051
.
(30 September 2025)
Research Article
AB050. The thymic epithelial tumors according to the new 2021 WHO classification: Tunisian experience
Mediastinum
2025;
9:
AB050
.
(30 September 2025)
Case Series
AB049. Continuing challenges of primary neuroendocrine neoplasms of the thymus: clinicopathological characteristics of an uncommon tumor in a case series
Mediastinum
2025;
9:
AB049
.
(30 September 2025)
Case Series
AB048. Thymoma in children, a rare mediastinal tumour: pathological case series of 6 cases and review of the literature
Mediastinum
2025;
9:
AB048
.
(30 September 2025)
Case Report
AB047. Mixed type A thymoma and micronodular thymoma with lymphoid stroma: a case report of an unusual tumor and literature review
Mediastinum
2025;
9:
AB047
.
(30 September 2025)
Case Report
AB046. Robotic resection of thymoma recurrence with intra thoracic phrenic nerve reconstruction using a sural nerve graft: a case report
Mediastinum
2025;
9:
AB046
.
(30 September 2025)
Case Report
AB045. Are complement inhibitors safe for thymoma-associated myasthenia gravis patients?—a literary review and case report
Mediastinum
2025;
9:
AB045
.
(30 September 2025)
Case Report
AB044. Late thymoma occurrence after thymectomy for thymic hyperplasia: case reports of our experience
Mediastinum
2025;
9:
AB044
.
(30 September 2025)
Original Research
AB043. Comparative analysis of surgical approaches and optimal resection extent in thymoma treatment
Mediastinum
2025;
9:
AB043
.
(30 September 2025)
Observational Retrospective Study (Original Research)
AB042. Robotic-assisted surgery for large thymomas: preliminary results on feasibility and safety in a single center experience
Mediastinum
2025;
9:
AB042
.
(30 September 2025)
Original Research
AB041. Treatment response after induction therapy in unresectable thymic tumors: TYME database analysis
Mediastinum
2025;
9:
AB041
.
(30 September 2025)
Original Research
AB040. Subclinical myasthenia gravis after thymectomy: a 20-year retrospective cohort study
Mediastinum
2025;
9:
AB040
.
(30 September 2025)
Original Research
AB039. Survival of Danish patients with thymic epithelial tumors: a nationwide cohort study
Mediastinum
2025;
9:
AB039
.
(30 September 2025)
Original Research
AB038. A 10-year retrospective review of recurrent thymomas: a single-centre experience
Mediastinum
2025;
9:
AB038
.
(30 September 2025)
Original Research
AB037. The safety of surgery plus hyperthermic intrathoracic chemotherapy perfusion in patients with IVa thymic epithelial tumors
Mediastinum
2025;
9:
AB037
.
(30 September 2025)
Original Research
AB036. Trends in thymic epithelial tumor patients in the Netherlands: a population-based study
Mediastinum
2025;
9:
AB036
.
(30 September 2025)
Case Report
AB035. PD-1 checkpoint inhibitors exhibit significant antitumor activity in patients with Masaoka stage IV thymoma: a case report
Mediastinum
2025;
9:
AB035
.
(30 September 2025)
Original Research
AB034. Weakly supervised artificial intelligence-based subtyping of thymic epithelial tumors using H&E whole slide images
Mediastinum
2025;
9:
AB034
.
(30 September 2025)
Original Research
AB033. Thymic cancer in France: a comprehensive analysis of incidence based on French National Healthcare Data—a retrospective observational study
Mediastinum
2025;
9:
AB033
.
(30 September 2025)
Original Research
AB032. Central pathology review of thymic tumors: updated analysis of diagnostic concordance in the French RYTHMIC cohort—a retrospective study
Mediastinum
2025;
9:
AB032
.
(30 September 2025)
Observational Epidemiological Study (Original Research)
AB031. Global patterns and trends in thymic epithelial tumors incidence: worldwide healthcare disparity on detection
Mediastinum
2025;
9:
AB031
.
(30 September 2025)
Original Research
AB030. Clinical significance of SUVmax as a predictor of pathological invasion and prognostic factor in advanced thymic epithelial tumors requiring a combined resection of adjacent organs and dissemination
Mediastinum
2025;
9:
AB030
.
(30 September 2025)
Original Research
AB029. Eculizumab as a new option for perioperative treatment in thymoma-associated myasthenia gravis: a prospective case series
Mediastinum
2025;
9:
AB029
.
(30 September 2025)
Original Research
AB028. Good’s syndrome and infections in a large retrospective cohort of thymoma
Mediastinum
2025;
9:
AB028
.
(30 September 2025)
Original Research
AB027. Surgery for de novo stage IVa thymomas: time to broaden our horizons?—a single-centre retrospective analysis
Mediastinum
2025;
9:
AB027
.
(30 September 2025)
Original Research
AB026. Contralateral pleura-sparing modified subxiphoid approach for robotic thymectomy: operative results, and advantages in metachronous lung cancer resection
Mediastinum
2025;
9:
AB026
.
(30 September 2025)
Case Report
AB025. When the thymus crosses the line: an unusual case of lung-infiltrating endobronchial thymoma—a case report
Mediastinum
2025;
9:
AB025
.
(30 September 2025)
Original Research
AB024. MIST: a weakly supervised deep learning system for multicenter diagnosis of mediastinal tumors
Mediastinum
2025;
9:
AB024
.
(30 September 2025)
Original Research
AB023. Thymic epithelial tumors and immune system: a particular relationship still to be clarified
Mediastinum
2025;
9:
AB023
.
(30 September 2025)
Original Research
AB022. Retrospective evaluation of cardiac toxicity during irradiation of thymic malignancies
Mediastinum
2025;
9:
AB022
.
(30 September 2025)
Original Research
AB021. A single-arm, multicenter, phase II trial of glucocorticoids induction followed by surgery for advanced thymomas with type B component
Mediastinum
2025;
9:
AB021
.
(30 September 2025)
Case Report
AB020. Salvage surgery following definitive chemoradiotherapy and immune checkpoint inhibitor therapy for locally advanced thymic carcinoma: a case report
Mediastinum
2025;
9:
AB020
.
(30 September 2025)
Original Research
AB019. Machine learning models from FDG PET/CT for predicting recurrence in thymomas
Mediastinum
2025;
9:
AB019
.
(30 September 2025)
Original Research
AB018. Targeted biologics for treating thymoma associated myasthenia gravis: a multicenter retrospective study
Mediastinum
2025;
9:
AB018
.
(30 September 2025)
Original Research
AB017. Clinicopathologic features, treatment outcomes, and survival in thymic neuroendocrine tumors: a 25-year single-center experience
Mediastinum
2025;
9:
AB017
.
(30 September 2025)
Original Research
AB016. Towards understanding mechanisms of thymectomy benefit for myasthenia gravis
Mediastinum
2025;
9:
AB016
.
(30 September 2025)
Original Research
AB015. Perioperative outcomes and surgical strategies in malignant anterior mediastinal tumors
Mediastinum
2025;
9:
AB015
.
(30 September 2025)
Original Research
AB014. Autoreactome analysis reveals novel autoantibodies in thymoma-associated myasthenia gravis
Mediastinum
2025;
9:
AB014
.
(30 September 2025)
Clinical Trial in Progress (Study Protocol)
AB013. A pivotal phase 2 trial to compare PRTH-101, a monoclonal antibody targeting discoidin domain receptor 1 (DDR1), in combination with an immune checkpoint inhibitor (ICI) and ICI alone, for the treatment of recurrent or metastatic thymic epithelial carcinoma (TEC)
Mediastinum
2025;
9:
AB013
.
(30 September 2025)
Original Research
AB012. Short-term outcome of robotic subxiphoid-optical thymectomy for malignant thymic epithelial tumors
Mediastinum
2025;
9:
AB012
.
(30 September 2025)
Case Report
AB011. Robot-assisted subxiphoid approach for resection of a giant cervicothoracic junction tumor: a case report
Mediastinum
2025;
9:
AB011
.
(30 September 2025)
Clinical Trial in Progress (Original Research)
AB010. A phase 1 trial of PRTH-101, a monoclonal antibody targeting discoidin domain receptor 1 (DDR1), alone or in combination with pembrolizumab, for the treatment of thymic malignancies
Mediastinum
2025;
9:
AB010
.
(30 September 2025)
Original Research
AB009. Review of case characteristics and exploration of mechanisms of thymoma shrinkage after glucocorticoid therapy
Mediastinum
2025;
9:
AB009
.
(30 September 2025)
Original Research
AB008. Analysis of natural development and changes of thymic cysts on imaging
Mediastinum
2025;
9:
AB008
.
(30 September 2025)
Original Research
AB007. The impact of immunological indicators on the prognosis of thymectomy in patients with thymoma-associated myasthenia gravis
Mediastinum
2025;
9:
AB007
.
(30 September 2025)
Original Research
AB006. Postoperative complications and early recurrence in surgically treated thymoma: a single-centre retrospective study
Mediastinum
2025;
9:
AB006
.
(30 September 2025)
Case Report
AB005. Metaplastic thymoma of the mediastinum—a clinicopathological report of three cases
Mediastinum
2025;
9:
AB005
.
(30 September 2025)
Original Research
AB004. Optimizing surgical strategies in mediastinal tumor resections through comparative analysis of hemi-clamshell and sternotomy techniques
Mediastinum
2025;
9:
AB004
.
(30 September 2025)
Original Research
AB003. Optimizing postoperative proton radiotherapy in thymic epithelial tumors: added value of breath hold?
Mediastinum
2025;
9:
AB003
.
(30 September 2025)
Original Research
AB002. Histopathological heterogeneity in resected thymomas
Mediastinum
2025;
9:
AB002
.
(30 September 2025)
Original Research
AB001. Robot-assisted thoracic surgery for thymic epithelial tumors: a real-world study of 143 cases
Mediastinum
2025;
9:
AB001
.
(30 September 2025)
Download the Full Issue PDF(2.21 MB)
Disclosure:
The “Abstract Book for the 15th International Thymic Malignancy Interest Group Annual Meeting (ITMIG 2025)” was commissioned by the editorial office, Mediastinum without any sponsorship or funding.
